Authors:
BRUGGER W
DIERKESMANN R
TOOMES H
ENGELHARDT R
HASSE J
PRESSLER K
KOLLMANNSBERGER C
SCHUMACHER M
FROMMHOLD H
BAMBERG M
KANZ L
Citation: W. Brugger et al., MULTICENTER RANDOMIZED PHASE-III STUDY EVALUATING THE ROLE OF HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER, Onkologie, 21, 1998, pp. 12-14
Authors:
BRUGGER W
FETSCHER S
HASSE J
FROMMHOLD H
PRESSLER K
MERTELSMANN R
ENGELHARDT R
KANZ L
Citation: W. Brugger et al., MULTIMODALITY TREATMENT INCLUDING EARLY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 42-48
Authors:
GUTTENBERGER R
LUTTERBACH J
ROTH A
ROSER S
SCHINDLER R
HENKE M
FROMMHOLD H
Citation: R. Guttenberger et al., HEMOGLOBIN LEVELS PREDICT LOCAL-REGIONAL CONTROL AFTER POSTOPERATIVE RADIOTHERAPY FOR ADVANCED HEAD AND NECK-CANCER, European journal of cancer, 33, 1997, pp. 452-452
Authors:
FETSCHER S
BRUGGER W
ENGELHARDT R
KANZ L
HASSE J
FROMMHOLD H
WENGER M
LANGE W
MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 100 CONSECUTIVE PATIENTS WITH, LIMITED-DISEASE AND EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 49-56
Authors:
FETSCHER S
BRUGGER W
ENGELHARDT R
KANZ L
HASSE J
FROMMHOLD H
WENGER M
LANGE W
MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 107 CONSECUTIVE PATIENTS WITH, LIMITED-STAGE AND EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 57-64
Authors:
DALL P
MEERPOHL HG
HENNE K
DUBOIS A
ACHTERRATH W
FROMMHOLD H
PFLEIDERER A
Citation: P. Dall et al., COMBINED RADIOCHEMOTHERAPY IN ADVANCED CERVICAL-CANCER - A PHASE-II TRIAL WITH WEEKLY APPLIED CARBOPLATIN, 5-FLUOROURACIL AND FOLINIC ACID, International journal of gynecological cancer, 6(1), 1996, pp. 20-26
Authors:
BRUGGER W
FROMMHOLD H
PRESSLER K
MERTELSMANN R
KANZ L
Citation: W. Brugger et al., USE OF HIGH-DOSE ETOPOSIDE IFOSFAMIDE CARBOPLATIN EPIRUBICIN AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER, Seminars in oncology, 22(1), 1995, pp. 3-8
Authors:
REINHARDT M
GUTTENBERGER R
SLANINA J
FROMMHOLD H
MOSER E
Citation: M. Reinhardt et al., INDICATIONS FOR EXTERNAL RADIOTHERAPY IN THE MANAGEMENT OF THYROID-CANCER - FREIBURG CONSENSUS, Radiologe, 35(8), 1995, pp. 535-539